Por vez primera, un sistema inteligente no orgánico ha diseñado, planificado y ejecutado un experimento químico. Esto ha sucedido gracias a labor de unos científicos de la Universidad Carnegie Mellon (CMU) en Estados Unidos “Prevemos que los sistema …
Llega el progreso científico automático, de la mano de la inteligencia artificial Read More »
The Food and Drug Administration labeled the recall as a Class I event. There has been one report of a machine exploding in the 22 years the system has been in use.
Philips recalls MRI machines due to risk of explosion Read More »
The 2022 report comes after regulators finalized merger guidelines this week that could have a chilling effect on healthcare M&A.
Antitrust enforcements hit a high in 2022, with health deals impacted Read More »
The suit alleges Salem Community Hospital and Perry Johnson & Associates waited months before informing affected individuals. The breach may have exposed the data of nearly nine million people across the country.
Ohio hospital, vendor hit with class action suit after data breach Read More »
Like its rival Philips, Resmed has determined that patients should not wear magnetized masks near some implants.
Resmed posts notice about risk of mask magnets interfering with medical implants Read More »
A día de hoy podemos hacer todo o casi todo a través de Internet, como ir al mercado, pedir cita en el médico, comprar un regalo e incluso enviar flores online, una excelente opción para esos momentos en los que queremos tener un detalle con una persona especial. …
Most of the reductions, which equal about 2% of the company’s global workforce, will be completed in the first quarter, Agilent said.
Agilent to lay off about 400 workers amid site closures Read More »
A shift in funding sources, new regulatory policies in Medicare and technology advances may influence M&A in the sector next year, according to Samantha Prokop from law firm Gunster, Yoakley & Stewart.
Predictions on 2024 healthcare M&A trends: What leaders need to know Read More »
Theseus Pharmaceuticals, Inc. today announced it has entered into a definitive merger agreement (the “Merger Agreement”) whereby Concentra Biosciences, LLC (“Concentra”) will acquire Theseus for a price per share of Theseus common stock.
Cellusion Inc., a deep tech start-up developing a novel cell therapy, announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to our regenerative medicine product “iPS cell-derived corneal endothelial cell substitute” for the treatment of bullous keratopathy.
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001 Read More »
